AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
India: Sun Pharma shares up on Caraco hopes.
MUMBAI, May 22. SHARES of Mumbai-based pharma major, Sun Pharmaceuticals Ltd, have been heading northwards, gaining 12 per cent over the last 23 days on the Bombay Stock Exchange (BSE).
The upward movement of the stock has been triggered by an announcement by Sun Pharma's joint venture company, Caraco Pharmaceutical Laboratories Ltd, that it has received US FDA (US Food & Drug Administration) approval for its two products, according to analysts tracking the pharmaceutical industry.
Caraco, in which Sun Pharma owns a 48.54 per cent stake, had on April 30, announced that it received US FDA approvals for Flurbiprofen tablets and Clonazepam tablets.
…
-
- Caraco announces merger agreement with Sun Pharma; Caraco public shareholders...
-
News wire article from: Chemical Business Newsbase
February 22, 2011
700+ words
-
- CORPORATE: 'Caraco warning letter not to impact revenues of Sun Pharma'.
-
News wire article from: Business Line
November 5, 2008
700+ words
-
- Sun Pharma to hike Caraco stake to 50%.
-
News wire article from: Asia Africa Intelligence Wire
October 3, 2002
700+ words
-
- Caraco to merge with Sun Pharma.
-
News wire article from: Chemical Business Newsbase
February 23, 2011
700+ words
-
- CORPORATE: Sun Pharma offers to buy out outstanding shares in Caraco.
-
News wire article from: Business Line
December 5, 2010
700+ words
